Loading insider details...
Beta
Latest Form 4 (Jul 28, 2026): Disposition to Issuer of 4,817 AVNS shares, $120.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | AVANOS MEDICAL, INC. (AVNS) | Disposition to Issuer | 4,817 | $120.4K |
| May 12, 2026 | AVANOS MEDICAL, INC. (AVNS) | Grant/Award | 12,003 | n/a |
| Jan 6, 2025 | AVANOS MEDICAL, INC. (AVNS) | Grant/Award | 12,003 | n/a |
| Feb 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 878 | n/a |
| Feb 5, 2024 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 5,175 | n/a |
| Apr 10, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Sale | 3,500 | $735.0K |
| Mar 1, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 2,632 | n/a |
| Feb 3, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 5,175 | n/a |
| Feb 10, 2022 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 15,525 | n/a |